NRP2 transcriptionally regulates its downstream effector WDFY1

Area of Science:

• Cell Biology
• Molecular Oncology
• Cancer Research

Background:

• Neuropilins (NRPs) are cell surface glycoproteins functioning as co-receptors.
• Neuropilin-2 (NRP2) also regulates autophagy and endocytic trafficking in cancer cells.
• WD Repeat and FYVE domain containing 1 (WDFY1) acts downstream of NRP2 in this non-co-receptor function.

Purpose of the Study:

• To delineate the molecular mechanism by which NRP2 regulates WDFY1 synthesis.
• To investigate the role of the NRP2-WDFY1 axis in maintaining the metastatic phenotype of cancer cells.

Main Methods:

• Investigated the transcriptional regulation of WDFY1 by NRP2.
• Identified Fetal ALZ50-reactive clone 1 (FAC1) as a transcription factor involved in WDFY1 regulation.
• Assessed the impact of NRP2-WDFY1 interaction on cancer cell endocytic activity and survival.

Main Results:

• NRP2 negatively regulates WDFY1 expression by inhibiting its transcription.
• NRP2 prevents the nuclear localization of the transcription factor FAC1, thereby suppressing WDFY1 transcription.
• Maintenance of optimal WDFY1 levels by NRP2 is crucial for high endocytic activity in metastatic cancer cells.
• This regulation supports oncogenic activation and cancer cell survival.

Conclusions:

• NRP2 transcriptionally regulates WDFY1, a novel finding for the NRP2 axis.
• The NRP2-WDFY1 regulatory axis is critical for maintaining the metastatic phenotype.
• Inhibiting NRP2 or enhancing WDFY1 activity presents a potential therapeutic strategy for inducing cell death in metastatic cancers.